Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risankizumab for Refractory Perianal Fistulizing Crohn's Disease
NCT07872449Phase 4Recruiting
- Start
- Oct 2026
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
A Phase 4 trial of risankizumab in Crohn's disease. Started Oct 2026; status: recruiting.
02
Drugs
risankizumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT07872449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07872449.